OKYO Pharma
OKYO • NASDAQ • Stock Fundamentals
OKYO Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert J. Dempsey, with a market cap of $87.1M.
Market Cap$87.1M
Employees3.0
CEORobert J. Dempsey
CountryUnited Kingdom
Healthcare
Biotechnology
Most Recent EarningsJan 30, 2026 · 3 months agoQ3 2025
View reportNext EarningsJun 3, 2026 · In 4 weeksQ1 2026
Financials
Based on Q3 2025 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metric
OKYO Pharma FAQ
Common questions about OKYO Pharma
OKYO Pharma (OKYO) has a market capitalization of $87.1M and trades on NASDAQ.
OKYO Pharma has approximately 3 employees.